NewLink (NLNK), Intrexon (XON), OraSure (OSUR) Highlighted on Zika - Mizuho
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Canaccord Genuity Reiterates Buy as OraSure Technologies (OSUR) Reports 4th Consecutive Quarter of Profit
February 4, 2016 9:59 AM ESTCanaccord Genuity reiterated a Buy rating and $8 price target on OraSure Technologies (NASDAQ: OSUR) following the company's 4Q earnings report. OSUR posted revenue of $32.4M, handily beating the Street's $29.8M estimate, as strength in the molecular collections systems segment and HCV sales... More
Zika Stock Intrexon (XON) Gains 5% Early
February 3, 2016 7:51 AM ESTZika stock Intrexon (NYSE: XON) is seeing early upside. Shares are up 5%.
NewLink Genetics (NLNK) Plans to Develop New Treatment Options for Zika Virus
February 2, 2016 8:59 AM ESTNewLink Genetics Corporation (NASDAQ: NLNK) today announced the company initiated a project... More
